✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Denali Therapeutics Inc

Common Name
Denali Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
517
Ticker
DNLI
Exchange
NASDAQ/NGS
Description
Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorder...

Denali Therapeutics's Financial Statements Preview

Below are the financial statements of Denali Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Collaboration revenue
Collaboration revenue from customers
0a
330.53a
105.07a
Other collaboration revenue
0a
0a
3.4a
Total collaboration revenue
0a
330.53a
108.46a
Operating expenses
Research and development
-396.44a
-423.88a
-358.73a
General and administrative
-105.44a
-103.35a
-90.48a
Total operating expenses
-501.88a
-527.23a
-449.21a
Gain from divestiture of small molecule programs
14.54a
0a
0a
Loss from operations
-487.34a
-196.7a
-340.74a
Interest and other income, net
64.64a
51.51a
14.77a
Loss before income taxes
-422.71a
-145.19a
-325.97a
Income tax expense
-0.07a
-0.03a
-0.02a
Net loss
-422.77a
-145.22a
-325.99a
Limited Data Preview
You are viewing a limited preview of Denali Therapeutics’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Denali Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Denali Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. Denali Therapeutics's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?